JIANGSU ALPHA PHARMACEUTICAL CO LTD SITE-II
Overview
JIANGSU ALPHA PHARMACEUTICAL CO LTD SITE-II is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering ACETOXY DAPAGLIFLOZIN; ACETOXY EMPAGLIFLOZIN; ATORVASTATIN CALCIUM TRIHYDRATE; EMPAGLIFLOZIN INTERMEDIATE (EG4); ROSUVASTATIN CALCIUM INTERMEDIATE (R1).
Core services & business areas
Active pharmaceutical ingredients supplied
Substances JIANGSU ALPHA PHARMACEUTICAL CO LTD SITE-II is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
JIANGSU ALPHA PHARMACEUTICAL CO LTD SITE-II holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ATORVASTATIN CALCIUM TRIHYDRATEActive2024-01-26
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGSU ALPHA PHARMACEUTICAL CO LTD SITE-II in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this JIANGSU ALPHA PHARMACEUTICAL CO LTD SITE-II? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.